Oviva

Name

Oviva

Legal name

Oviva AG

Website

https://oviva.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Oviva is a Swiss-founded European digital health company that delivers AI-enabled, reimbursed digital therapy for obesity, type 2 diabetes and hypertension via a CE-marked app and a 420+ clinician team across the UK, Germany, Switzerland, France and Poland, serving more than one million patients.

Ownership category

akta.pro rank

Product category

Digital Therapeutics

NAICS

Other Ambulatory Health Care Services (6219), Offices of Physicians (62111)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE)

akta.pro secondary industry

Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD)

Keywords

• Digital health therapeutics
• Chronic disease management
• Behaviour change coaching
• Medical device software
• Weight management programmes

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Healthcare-system reimbursement: Primary recurring revenue stream comes from reimbursement by national healthcare systems and statutory/private health insurers: certified DiGA in Germany, NHS contracts in the UK, and integration into Swiss public healthcare. Care is delivered remotely via the app and coaching teams, generating recurring per-patient revenue under multi-year framework contracts.
2. Weight-loss medication dispensing partnership (UK): Oviva manages NHS Tier 3 Weight Management programmes including weight loss injections (e.g. Wegovy) for eligible patients; medication is dispensed by partner pharmacy Chemist 4 U as part of the bundled care package funded by the NHS.
3. Swiss integrated care packages: In Switzerland Oviva sells bundled programmes combining medication therapy, nutritional counseling, psychotherapy and sports medicine, covered by Swiss health insurance with a medical prescription.

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels8 records

Core offering

Oviva sells a CE-marked, EU MDR Class IIa medical-device app (the Oviva App) that delivers personalised dietary advice, AI photo-based meal logging, activity and weight tracking, and remote coaching, on top of which it operates indication-specific reimbursed programmes: the German DiGAs Oviva Direkt (obesity) and Oviva Direkt Bluthochdruck (hypertension), UK NHS-partnered Tier 3 Weight Management (with weight-loss medication), Type 2 Diabetes Path to Remission, and the NHS Diabetes Prevention Programme, plus Swiss integrated care packages (OvivaMed medication therapy, nutritional counselling, psychotherapy, sports medicine). Care is funded by healthcare-system reimbursement (NHS, German statutory insurers, Swiss public health insurance) at no direct cost to eligible patients.

Product overview

Oviva operates a unified digital-health platform anchored by the CE-marked Oviva App, on top of which a portfolio of country-specific, indication-specific programmes and DiGAs is delivered. The core Oviva App provides AI-powered meal logging, nutrition/activity compasses, goal setting and secure chat across all markets, while regional products layer on top: in Germany, two certified DiGAs — Oviva Direkt for Obesity (permanently listed since 2023) and Oviva Direkt Bluthochdruck for essential hypertension (listed January 2026); in the UK, NHS-partnered Tier 3 Weight Management, the Type 2 Diabetes Path to Remission Programme and the NHS Diabetes Prevention Programme; and in Switzerland, the Ovivamed medication-assisted obesity programme, dietary counselling, blended psychotherapy, and Virtual Oviva Clinics launched in 2024. Together these products form a single reimbursement-ready care pathway for weight-related and chronic conditions across Germany, the UK, and Switzerland.

Differentiator

Problem solved

Functional benefit

Brands

• Oviva Direkt: Certified German DiGA (digital health application) for obesity, listed in the BfArM DiGA directory from October 2021 with permanent listing granted in 2023; reimbursed by statutory health insurance in Germany.
• Oviva Direkt Bluthochdruck
• Oviva Clinic
• Ovivamed

Products and services

• Oviva App Medical-device-certified (CE-marked, EU MDR Class IIa) smartphone app that supports dietetic care through personalised dietary advice, AI-powered photo meal logging, activity and weight tracking, goal setting, instant personalised feedback and chat with healthcare professionals; the central delivery platform across all Oviva markets.
• Oviva Direkt for Obesity German DiGA (digital health application) prescribed app for the treatment of obesity; permanently listed in the BfArM DiGA directory since 2023 and fully reimbursed by all German statutory health insurers; clinical evidence from the AMODA RCT demonstrates significant weight reduction.
• Oviva Direkt Bluthochdruck (Oviva Direkt for Hypertension) DiGA listed in the BfArM directory in January 2026 for essential hypertension; the first DiGA with dual-effect on blood pressure and weight, based on the HYPE trial.
• Ovivamed — Obesity Therapy with Medication Swiss offering combining medication therapy (weight-loss injections such as Wegovy/Mounjaro) with personalised nutritional counselling, psychotherapy and sports medicine, supported remotely by the Oviva App and covered by Swiss health insurance with a medical prescription.
• Oviva Tier 3 Weight Management (UK) NHS-partnered specialist weight-management programme delivered remotely via the Oviva App, combining 1-to-1 coaching with dietitians, psychologists and doctors with prescription weight-loss medication (e.g. Wegovy); reported 15% average body-weight loss at 12 months; rated 'Good' by the Care Quality Commission.
• Oviva Type 2 Diabetes Path to Remission Programme UK NHS service supporting patients through low-calorie and weight-management pathways to achieve Type 2 diabetes remission, with evidence published in The Lancet Diabetes & Endocrinology (2024).
• NHS Diabetes Prevention Programme (NDPP) — Oviva delivery UK delivery of the NHS Diabetes Prevention Programme (NDPP), a behaviour-change programme for adults at high risk of Type 2 diabetes, delivered remotely via the Oviva App with coaching.
• Oviva Psychotherapy (Switzerland) Outpatient blended psychotherapy in Switzerland combining on-site sessions with video consultations and app-guided interventions; treats the full spectrum of behavioural-medicine disorders with a multidisciplinary team of federally recognised psychotherapists.
• Virtual Oviva Clinics Virtual Oviva Clinics launched in the UK and Switzerland offering medical support therapy alongside the digital programme, providing a more holistic care pathway beyond nutritional counselling.

Named customers10 records

Segments5 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability10 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered core, minor and flagship.

• Chemist 4 U (Innox Trading Ltd)coreChannel Partner/ Reseller/ Distributor · 1 January 2024Oviva's UK partner pharmacy (GPhC registration 9011784) that dispenses weight-loss medication (e.g. Wegovy) as part of the Oviva Tier 3 Weight Management service bundle for NHS patients.
• Strand PartnersminorGTM or Marketing Partner · 1 January 2024Oviva's PR agency of record; handles press contact ([email protected]), press distribution and media relations across global markets.
• Nicole BreforthminorGTM or Marketing Partner · 1 January 2024Oviva's named press contact in Germany ([email protected]), handling German-language media relations.
• T-Systems (sovereign cloud powered by Google Cloud)coreTechnology or Integration · 25 July 2023Oviva moved its infrastructure to the T-Systems Sovereign Cloud powered by Google Cloud in July 2023 to accelerate growth, provide patients easier access to care and meet European data-residency / sovereignty requirements.
• NICE (National Institute for Health and Care Excellence, UK)coreStrategic or Co-development Partner · 1 January 2023NICE recommended Oviva to deliver digital Tier 3 Weight Management services with weight loss medications within the NHS.
• BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)flagshipStrategic or Co-development Partner · 1 October 2021German Federal Institute for Drugs and Medical Devices that lists Oviva Direkt for obesity in the DiGA directory (since October 2021; permanent listing 2023) and Oviva Direkt Bluthochdruck for hypertension (since January 2026).
• European healthcare provider networkcoreChannel Partner/ Reseller/ Distributor · 31 August 2021Oviva had established partnerships with more than 5,000 health organizations across Europe by 2021 (referring doctors, clinics, health insurers); it expanded care for 30,000+ doctors by 2025.
• NHS (UK National Health Service)flagshipStrategic or Co-development Partner · 1 January 2019Oviva is an NHS partner delivering the NHS Diabetes Prevention Programme (NDPP), NHS Tier 3 Weight Management (rated 'Good' by CQC), Type 2 Diabetes Path to Remission Programme, and structured education (e.g. NHS North East London). Oviva has supported over 300,000 NHS patients and is DTAC-accredited.
• Swiss Federal Office of Public Health (BAG)coreStrategic or Co-development Partner · 1 January 2018In 2018 Oviva was recognised by the Swiss Federal Office of Public Health as a 'Model of Good Practice' and won first prize at the Forum of Managed Care; Oviva's care is integrated into Swiss public healthcare.

Scale indicators17 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Noom: Noom is a US-headquartered digital weight-management platform combining app-based coaching, behaviour change content and meal logging — directly comparable to Oviva's app-led lifestyle coaching for obesity and diabetes. Both sell directly to consumers and to enterprise/payer channels, and both have been expanding GLP-1 companion programmes.
• Omada Health: Omada Health is a US digital chronic-care platform (diabetes prevention, hypertension, behavioural health) reimbursed by employers, payers and the US CDC's National DPP. Highly comparable to Oviva's NHS Diabetes Prevention Programme and DiGA offerings, with the same evidence-based, payer-integrated model.
• Virta Health: Virta Health is a US digital therapeutics company that pioneered telehealth-supervised type 2 diabetes reversal using low-carbohydrate nutrition and remote coaching. Directly comparable to Oviva's NHS Type 2 Diabetes Path to Remission Programme and Swiss OvivaMed medication-bundled care.
• Liva Healthcare: Liva Healthcare is a European digital health-coaching platform delivering NHS Diabetes Prevention Programme and weight-management programmes in the UK and Nordics. Closest UK/Nordic peer to Oviva's NHS Tier 3 and NDPP delivery model.
• Second Nature: Second Nature is a UK digital weight-management provider delivering the NHS Type 2 Diabetes Path to Remission and Tier 3 Weight Management programmes alongside commercial GLP-1 support. Direct UK competitor to Oviva on the same NHS frameworks.
• HelloBetter: HelloBetter is a German digital therapeutics company with multiple BfArM-listed DiGAs in mental health and chronic conditions. Shares Oviva's DiGA-first reimbursement model and CE-marked digital therapeutic approach in the German market.
• Sidekick Health: Sidekick Health is a Nordic digital therapeutics company addressing obesity, diabetes and other chronic conditions through app-based, reimbursed programmes across Europe. Comparable to Oviva's reimbursed chronic-care platform model and European multi-payer footprint.
• Kaia Health: Kaia Health is a digital therapeutics company offering app-based programmes for chronic pain, COPD and musculoskeletal conditions, with growing obesity content. Overlaps with Oviva's app-delivered, evidence-based chronic-care model and European reimbursement push, though focused on different indications.

Broad incumbents

• WW International (Weight Watchers): WW International is a long-established, global weight-management incumbent that has pivoted to digital coaching, GLP-1 companion programmes and employer channels. Overlaps with Oviva's digital lifestyle coaching but operates at much wider scale and lacks DiGA/NHS payer integration.
• mySugr (Roche Diabetes Care): mySugr is a Vienna-based, Roche-owned diabetes self-management app that logs blood glucose, meals and activity. Comparable to Oviva's app-led diabetes support and dietary advice, but sits inside a large diabetes-device incumbent rather than as a reimbursed digital therapeutic.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/in/kai-eberhardt-b1a90aa
• Xx.com/OvivaHealth
• Facebookfacebook.com/OvivaUK

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries1 record

Funding overview

Funding rounds8 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oviva